97 related articles for article (PubMed ID: 24924553)
1. Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis.
Rieken M; Djajadiningrat RS; Kluth LA; Favaretto RL; Xylinas E; Guimaraes GC; Soares FA; Kent M; Sjoberg DD; Horenblas S; Shariat SF
Eur Urol; 2014 Nov; 66(5):811-4. PubMed ID: 24924553
[TBL] [Abstract][Full Text] [Related]
2. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
[TBL] [Abstract][Full Text] [Related]
3. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients.
Leijte JA; Kirrander P; Antonini N; Windahl T; Horenblas S
Eur Urol; 2008 Jul; 54(1):161-8. PubMed ID: 18440124
[TBL] [Abstract][Full Text] [Related]
4. Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis.
Sun M; Djajadiningrat RS; Alnajjar HM; Trinh QD; Graafland NM; Watkin N; Karakiewicz PI; Horenblas S
BJU Int; 2015 Nov; 116(5):734-43. PubMed ID: 24552303
[TBL] [Abstract][Full Text] [Related]
5. Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.
Mistretta FA; Palumbo C; Knipper S; Mazzone E; Pecoraro A; Tian Z; Musi G; Perrotte P; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
World J Urol; 2020 Mar; 38(3):725-732. PubMed ID: 31297629
[TBL] [Abstract][Full Text] [Related]
6. Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.
Thuret R; Sun M; Abdollah F; Budaus L; Shariat SF; Iborra F; Guiter J; Patard JJ; Karakiewicz PI
BJU Int; 2013 Apr; 111(4 Pt B):E174-9. PubMed ID: 23057865
[TBL] [Abstract][Full Text] [Related]
7. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
[TBL] [Abstract][Full Text] [Related]
9. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
10. Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence.
Lont AP; Gallee MP; Meinhardt W; van Tinteren H; Horenblas S
J Urol; 2006 Aug; 176(2):575-80; discussion 580. PubMed ID: 16813892
[TBL] [Abstract][Full Text] [Related]
11. A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis.
May M; Brookman-May S; Burger M; Koch S; Otto W; Bründl J; Albrecht K; Denzinger S
Pathol Res Pract; 2015 Sep; 211(9):641-5. PubMed ID: 26092595
[TBL] [Abstract][Full Text] [Related]
12. Impact of County Rurality and Urologist Density on the Practice of Inguinal Lymph Node Dissection and Mortality in Patients Diagnosed with Squamous Cell Carcinoma of the Penis.
Romanelli M; Issa T; Zahnd W; Dynda D; Alanee S
Ann Surg Oncol; 2018 Jan; 25(1):334-341. PubMed ID: 29110272
[TBL] [Abstract][Full Text] [Related]
13. A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis.
Thuret R; Sun M; Budaus L; Abdollah F; Liberman D; Shariat SF; Iborra F; Guiter J; Patard JJ; Perrotte P; Karakiewicz PI
Cancer Causes Control; 2013 Jan; 24(1):71-9. PubMed ID: 23109172
[TBL] [Abstract][Full Text] [Related]
14. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of regional nodes in penile cancer-improvement of survival?
Djajadiningrat RS; Graafland NM; van Werkhoven E; Meinhardt W; Bex A; van der Poel HG; van Boven HH; Valdés Olmos RA; Horenblas S
J Urol; 2014 Jan; 191(1):68-73. PubMed ID: 23917166
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in penile cancer patient characteristics and treatment rates across the United States.
Scheipner L; Cano Garcia C; Barletta F; Incesu RB; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Chun FKH; Briganti A; Tilki D; Longo N; Carmignani L; Leitsmann M; Ahyai S; Karakiewicz PI
Cancer Epidemiol; 2023 Oct; 86():102424. PubMed ID: 37506474
[TBL] [Abstract][Full Text] [Related]
17. Glansectomy as Primary Management of Penile Squamous Cell Carcinoma: An International Study Collaboration.
Tang DH; Yan S; Ottenhof SR; Draeger D; Baumgarten AS; Chipollini J; Protzel C; Zhu Y; Ye DW; Hakenberg OW; Horenblas S; Watkin NA; Spiess PE
Urology; 2017 Nov; 109():140-144. PubMed ID: 28818536
[TBL] [Abstract][Full Text] [Related]
18. Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis.
Ager M; Njoku K; Serra M; Robinson A; Pickering L; Afshar M; Vyas L; Eardley I; Kayes O; Elmamoun M; Khoo V; Ayres B; Henry A; Watkin N; Tree AC
BJU Int; 2021 Oct; 128(4):451-459. PubMed ID: 33249744
[TBL] [Abstract][Full Text] [Related]
19. Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.
Moschini M; Sharma V; Zattoni F; Quevedo JF; Davis BJ; Kwon E; Karnes RJ
Eur Urol; 2016 Jan; 69(1):135-42. PubMed ID: 25865061
[TBL] [Abstract][Full Text] [Related]
20. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
